Related Experiment Video
Updated: May 4, 2026

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
41.6K
CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(-/-) mice
Jianchang Zhou1, Paul C Dimayuga1, Xiaoning Zhao1
1Oppenheimer Atherosclerosis Research Center, Division of Cardiology, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States.
Biochemical and Biophysical Research Communications
|December 18, 2013
Summary
CD8(+)CD25(+) T cells, a specific immune cell subtype, were found to protect against atherosclerosis in mice. These cells suppress immune responses, reducing plaque development and offering a potential new therapeutic target for cardiovascular disease.
Area of Science:
- Immunology
- Cardiovascular Research
Background:
- CD8(+) T cells are implicated in atherosclerosis.
- The specific role of CD8(+)CD25(+) T cells in this disease is unknown.
- CD8(+)CD25(+) T cells are known to suppress immune signaling.
Purpose of the Study:
- To investigate the phenotype and function of CD8(+)CD25(+) T cells in experimental atherosclerosis.
- To determine the atheroprotective potential of CD8(+)CD25(+) T cells.
Main Methods:
- Atherosclerosis was induced in apoE(-/-) mice on a hypercholesterolemic diet.
- Flow cytometry and CFSE-based proliferation assays were used for characterization.
- Adoptive transfer experiments were performed.
Main Results:
- CD8(+)CD25(+) T cells were identified within atherosclerotic plaques.
- These cells exhibited suppressive functions.
- Depletion of CD8(+)CD25(+) T cells enhanced CD8(+)CD25(-) T cell cytolytic activity.
- Adoptive transfer reduced CD4(+) T cell proliferation and atherosclerosis.
Conclusions:
- CD8(+)CD25(+) T cells play an athero-protective role in experimental atherosclerosis.
- This T cell subset may represent a novel therapeutic target for atherosclerosis.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Inflammation
46.6K
Overview
46.6K

